{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:01:58Z","timestamp":1791212518474,"version":"4.1.0"},"reference-count":92,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:p>The induction of hepatic drug metabolizing enzymes alters not only the metabolism of the xenobiotic substances that induce them but also the metabolism of various endogenous hormones. The xenobiotic receptor constitutive androstane receptor (CAR) (NR1I3) mediates the well-studied induction of CYP2B genes and other drug-metabolizing enzymes by phenobarbital (PB), an antiepileptic drug that has been shown to alter thyroid hormone (TH) levels. Here we show that CAR is required for PB-mediated disruption of TH homeostasis and the induction of thyroid follicular cell proliferation. Treatment with PB or the more potent and more effective CAR ligand 1, 4-bis-[2-(3, 5,-dichloropyridyloxy)] benzene resulted in universal induction of thyroid hormone glucuronidation and sulfation pathways in a CAR-dependent manner. This resulted in a decrease in serum T4 concentration and a concomitant increase in serum TSH levels. CAR activation also decreased serum T3 levels in mice in which T3 production was blocked. The increase in serum TSH levels resulted in the stimulation of thyroid-follicular cell proliferation. These results highlight the central role of the xenosensor CAR in drug-hormone interactions.<\/jats:p>","DOI":"10.1210\/en.2004-1350","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T01:34:02Z","timestamp":1101346442000},"page":"995-1002","source":"Crossref","is-referenced-by-count":161,"title":["Role of the Constitutive Androstane Receptor in Xenobiotic-Induced Thyroid Hormone Metabolism"],"prefix":"10.1210","volume":"146","author":[{"given":"Mohammed","family":"Qatanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613171537900_R1","first-page":"10","article-title":"Pathways of TH metabolism.","volume":"23","author":"Visser","year":"1996","journal-title":"Acta Med Austriaca"},{"key":"2020071613171537900_R2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1289\/ehp.011091197","article-title":"Cognitive effects of endocrine-disrupting chemicals in animals.","volume":"109","author":"Schantz","year":"2001","journal-title":"Environ Health Perspect"},{"key":"2020071613171537900_R3","first-page":"306","article-title":"Peripheral metabolism of TH: a review.","volume":"5","author":"Kelly","year":"2000","journal-title":"Altern Med Rev"},{"key":"2020071613171537900_R4","doi-asserted-by":"crossref","first-page":"S2\u2013S6","DOI":"10.1016\/0003-4975(93)90548-V","article-title":"Comparative pharmacology of the TH.","volume":"56","author":"Sypniewski","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"2020071613171537900_R5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071613171537900_R6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0163-7258(89)90122-8","article-title":"UDP-glucuronosyltransferases.","volume":"43","author":"Burchell","year":"1989","journal-title":"Pharmacol Ther"},{"key":"2020071613171537900_R7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/endo-122-1-153","article-title":"Effects of inhibition of type I iodothyronine deiodinase and phenol sulfotransferase on the biliary clearance of triiodothyronine in rats.","volume":"122","author":"Herder","year":"1988","journal-title":"Endocrinology"},{"key":"2020071613171537900_R8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0009-2797(94)90071-X","article-title":"Role of sulfation in TH metabolism.","volume":"92","author":"Visser","year":"1994","journal-title":"Chem Biol Interact"},{"key":"2020071613171537900_R9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-5793(93)81134-L","article-title":"Multiple UDP-glucuronyltransferases for the glucuronidation of TH with preference for 3,3\u2032,5\u2032-triiodothyronine (reverse T3).","volume":"315","author":"Visser","year":"1993","journal-title":"FEBS Lett"},{"key":"2020071613171537900_R10","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/endo.138.12.5555","article-title":"Characterization of iodothyronine sulfotransferase activity in rat liver.","volume":"138","author":"Kaptein","year":"1997","journal-title":"Endocrinology"},{"key":"2020071613171537900_R11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0009-2797(97)00139-7","article-title":"Characterization of TH sulfotransferases.","volume":"109","author":"Visser","year":"1998","journal-title":"Chem Biol Interact"},{"key":"2020071613171537900_R12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0041-008X(89)90004-5","article-title":"The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.","volume":"99","author":"McClain","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/019262301301418838","article-title":"Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and TH metabolism.","volume":"29","author":"Klaassen","year":"2001","journal-title":"Toxicol Pathol"},{"key":"2020071613171537900_R14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/taap.1999.8752","article-title":"Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy.","volume":"160","author":"Hood","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R15","first-page":"977","article-title":"Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.","volume":"273","author":"Liu","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071613171537900_R16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/taap.1994.1174","article-title":"Reduction of TH levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.","volume":"128","author":"Barter","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1442-200X.1993.tb03018.x","article-title":"Serum TH and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication.","volume":"35","author":"Yuksel","year":"1993","journal-title":"Acta Paediatr Jpn"},{"key":"2020071613171537900_R18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism.","volume":"40","author":"Eiris-Punal","year":"1999","journal-title":"Epilepsia"},{"key":"2020071613171537900_R19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000120309","article-title":"Thyroid function in children with long-term anticonvulsant treatment.","volume":"13","author":"Tanaka","year":"1987","journal-title":"Pediatr Neurosci"},{"key":"2020071613171537900_R20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/carcin\/3.10.1187","article-title":"Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine.","volume":"3","author":"Hiasa","year":"1982","journal-title":"Carcinogenesis"},{"key":"2020071613171537900_R21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0041-008X(88)90267-0","article-title":"Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital.","volume":"94","author":"McClain","year":"1988","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0378-4274(92)90213-4","article-title":"Thyroid gland neoplasia: non-genotoxic mechanisms.","author":"McClain","year":"1992","journal-title":"Toxicol Lett"},{"key":"2020071613171537900_R23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/019262338901700206","article-title":"The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia.","volume":"17","author":"McClain","year":"1989","journal-title":"Toxicol Pathol"},{"key":"2020071613171537900_R24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/07853890310008224","article-title":"Drug-activated nuclear receptors CAR and PXR.","volume":"35","author":"Honkakoski","year":"2003","journal-title":"Ann Med"},{"key":"2020071613171537900_R25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1389200033336739","article-title":"A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.","volume":"4","author":"Sonoda","year":"2003","journal-title":"Curr Drug Metab"},{"key":"2020071613171537900_R26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/35038112","article-title":"The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.","volume":"407","author":"Wei","year":"2000","journal-title":"Nature"},{"key":"2020071613171537900_R27","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR.","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev"},{"key":"2020071613171537900_R28","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","article-title":"The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR.","volume":"33","author":"Sugatani","year":"2001","journal-title":"Hepatology"},{"key":"2020071613171537900_R29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.tpj.6500087","article-title":"Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response.","volume":"2","author":"Wei","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"2020071613171537900_R30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol Pharmacol"},{"key":"2020071613171537900_R31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/mol.62.2.359","article-title":"Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor.","volume":"62","author":"Goodwin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"2020071613171537900_R32","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/dmd.30.8.918","article-title":"Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1\/2 by phenobarbital.","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"2020071613171537900_R33","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR).","volume":"100","author":"Huang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613171537900_R34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1124\/mol.65.2.292","article-title":"A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification.","volume":"65","author":"Saini","year":"2004","journal-title":"Mol Pharmacol"},{"key":"2020071613171537900_R35","doi-asserted-by":"crossref","first-page":"22250","DOI":"10.1074\/jbc.M314111200","article-title":"Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice.","volume":"279","author":"Assem","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613171537900_R36","doi-asserted-by":"crossref","first-page":"19832","DOI":"10.1074\/jbc.M313601200","article-title":"The nuclear receptor CAR is a regulator of TH metabolism during caloric restriction.","volume":"279","author":"Maglich","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613171537900_R37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1210\/endo-128-2-741","article-title":"Thyroxine and 3,3\u2032,5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases.","volume":"128","author":"Beetstra","year":"1991","journal-title":"Endocrinology"},{"key":"2020071613171537900_R38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/taap.1999.8883","article-title":"Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward TH in various rat tissues.","volume":"163","author":"Hood","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R39","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.00046.2003","article-title":"Characterization of rat iodothyronine sulfotransferases","volume":"285","author":"Kester","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613171537900_R40","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/endo.136.11.7588215","article-title":"Effect of 3,5,3\u2032-triiodothyronine (T3) administration on dio1 gene expression and T3 metabolism in normal and type 1 deiodinase-deficient mice.","volume":"136","author":"Maia","year":"1995","journal-title":"Endocrinology"},{"key":"2020071613171537900_R41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endo-97-1-91","article-title":"Rapid effects of single small doses of l-thyroxine and triiodo-l-thyronine on growth hormone, as studied in the rat by radioimmunoassay.","volume":"97","author":"Hervas","year":"1975","journal-title":"Endocrinology"},{"key":"2020071613171537900_R42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/eje.0.1430733","article-title":"Changes in plasma TH levels after a single dose of triiodothyronine in premature infants of less than 30 weeks gestational age.","volume":"143","author":"Cools","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071613171537900_R43","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/endo-98-4-1031","article-title":"The mechanism of action of the thioureylene antithyroid drugs.","volume":"98","author":"Taurog","year":"1976","journal-title":"Endocrinology"},{"key":"2020071613171537900_R44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-43-1-152","article-title":"Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.","volume":"43","author":"Nagasaka","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613171537900_R45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/endo-110-1-190","article-title":"Preferential inhibition of thyroxine and 3,5,3\u2032-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.","volume":"110","author":"Engler","year":"1982","journal-title":"Endocrinology"},{"key":"2020071613171537900_R46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(93)90136-K","article-title":"Increased glucuronidation of TH in hexachlorobenzene-treated rats.","volume":"45","author":"Raaij","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"2020071613171537900_R47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/toxsci\/65.2.184","article-title":"Effect of microsomal enzyme inducers on the biliary excretion of triiodothyronine (T(3)) and its metabolites.","volume":"65","author":"Vansell","year":"2002","journal-title":"Toxicol Sci"},{"key":"2020071613171537900_R48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2001.9278","article-title":"Increased biliary excretion of thyroxine by microsomal enzyme inducers.","volume":"176","author":"Vansell","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"2020071613171537900_R49","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1006\/bbrc.1999.1419","article-title":"Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases.","volume":"263","author":"Li","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613171537900_R50","first-page":"1357","article-title":"Characterization of human iodothyronine sulfotransferases.","volume":"84","author":"Kester","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613171537900_R51","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1210\/jcem.84.7.5975","article-title":"Sulfation of TH by estrogen sulfotransferase.","volume":"84","author":"Kester","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613171537900_R52","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0006-2952(00)00475-5","article-title":"Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)*.","volume":"60","author":"Li","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"2020071613171537900_R53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1096\/fasebj.11.6.9194521","article-title":"Sulfation and sulfotransferases 5: the importance of 3\u2032-phosphoadenosine 5\u2032-phosphosulfate (PAPS) in the regulation of sulfation.","volume":"11","author":"Klaassen","year":"1997","journal-title":"FASEB J"},{"key":"2020071613171537900_R54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/104454903321112460","article-title":"The mouse sulfate anion transporter gene Sat1 (Slc26a1): cloning, tissue distribution, gene structure, functional characterization, and transcriptional regulation TH.","volume":"22","author":"Lee","year":"2003","journal-title":"DNA Cell Biol"},{"key":"2020071613171537900_R55","first-page":"G656","article-title":"Multispecific anion exchange in basolateral (sinusoidal) rat liver plasma membrane vesicles","volume":"251","author":"Hugentobler","year":"1986","journal-title":"Am J Physiol"},{"key":"2020071613171537900_R56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000184141","article-title":"Thyroid tumorigenesis.","volume":"42","author":"Williams","year":"1994","journal-title":"Horm Res"},{"key":"2020071613171537900_R57","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1210\/endo.133.5.8404669","article-title":"Glucuronidation of TH in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions.","volume":"133","author":"Visser","year":"1993","journal-title":"Endocrinology"},{"key":"2020071613171537900_R58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease.","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2020071613171537900_R59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on TH and the thyroid gland.","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr Rev"},{"key":"2020071613171537900_R60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1210\/endo-116-3-901","article-title":"Characterization of thyrotropin-induced increase in iodothyronine monodeiodinating activity in mice.","volume":"116","author":"Wu","year":"1985","journal-title":"Endocrinology"},{"key":"2020071613171537900_R61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-99-3-341","article-title":"Thyroxine replacement requirements in hypothyroid patients receiving phenytoin.","volume":"99","author":"Blackshear","year":"1983","journal-title":"Ann Intern Med"},{"key":"2020071613171537900_R62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/mol.65.6.1397","article-title":"The constitutive active\/androstane receptor regulates phenytoin induction of Cyp2c29.","volume":"65","author":"Jackson","year":"2004","journal-title":"Mol Pharmacol"},{"key":"2020071613171537900_R63","doi-asserted-by":"crossref","first-page":"29295","DOI":"10.1074\/jbc.M400580200","article-title":"Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin.","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613171537900_R64","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2265.1987.tb00831.x","article-title":"Circulating TSH levels measured with an immunochemiluminometric assay in patients taking drugs interfering with biochemical thyroid status.","volume":"26","author":"Evans","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613171537900_R65","first-page":"80","article-title":"Effect of antiepileptic drugs on the thyroid gland in children with epilepsy (preliminary report).","volume":"40","author":"Chakova","year":"1998","journal-title":"Folia Med (Plovdiv)"},{"key":"2020071613171537900_R66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2265.1985.tb01100.x","article-title":"Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment.","volume":"23","author":"Hegedus","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613171537900_R67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s004200000213","article-title":"Plasma concentrations of persistent organochlorines in relation to thyrotropin and TH levels in women.","volume":"74","author":"Hagmar","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"2020071613171537900_R68","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1203\/00006450-199410000-00009","article-title":"Effects of dioxins and polychlorinated biphenyls on TH status of pregnant women and their infants.","volume":"36","author":"Koopman-Esseboom","year":"1994","journal-title":"Pediatr Res"},{"key":"2020071613171537900_R69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/toxsci\/66.1.54","article-title":"Nonadditive hepatic tumor promoting effects by a mixture of two structurally different polychlorinated biphenyls in female rat livers.","volume":"66","author":"Dean Jr","year":"2002","journal-title":"Toxicol Sci"},{"key":"2020071613171537900_R70","first-page":"36","article-title":"Hexachlorobenzene episode in Turkey.","volume":"2","author":"Gocmen","year":"1989","journal-title":"Biomed Environ Sci"},{"key":"2020071613171537900_R71","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.103.054866","article-title":"Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.","volume":"307","author":"Lamba","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071613171537900_R72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00007691-198712000-00006","article-title":"Chronic antiepileptic drug therapy: classification by medication regimen and incidence of decreases in serum thyroxine and free thyroxine index.","volume":"9","author":"Haidukewych","year":"1987","journal-title":"Ther Drug Monit"},{"key":"2020071613171537900_R73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/phgs.4.2.141.22639","article-title":"Predicting inductive drug-drug interactions.","volume":"4","author":"Liddle","year":"2003","journal-title":"Pharmacogenomics"},{"key":"2020071613171537900_R74","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.","volume":"42","author":"Wang","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"2020071613171537900_R75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1552-6909.1983.tb01082.x","article-title":"Managing drug interactions with oral contraceptives.","volume":"12","author":"Stoehr","year":"1983","journal-title":"JOGN Nurs"},{"key":"2020071613171537900_R76","first-page":"2743","article-title":"Oral contraceptive and antiepileptic drug interaction resulting in contraceptive failure.","volume":"241","author":"Lewis","year":"1979","journal-title":"JAMA"},{"key":"2020071613171537900_R77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2008-1041375","article-title":"Sex hormones in stroke, chorea, and anticonvulsant therapy.","volume":"8","author":"Schipper","year":"1988","journal-title":"Semin Neurol"},{"key":"2020071613171537900_R78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199007123230204","article-title":"Increased need for thyroxine during pregnancy in women with primary hypothyroidism.","volume":"323","author":"Mandel","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071613171537900_R79","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJM199410203311608","article-title":"Maternal and fetal thyroid function.","volume":"331","author":"Burrow","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071613171537900_R80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa040079","article-title":"Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.","volume":"351","author":"Alexander","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613171537900_R81","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/clinchem\/45.12.2250","article-title":"Thyroid function during pregnancy.","volume":"45","author":"Fantz","year":"1999","journal-title":"Clin Chem"},{"key":"2020071613171537900_R82","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM200106073442310","article-title":"Estrogen, thyroxine binding in serum, and thyroxine therapy.","volume":"344","author":"Utiger","year":"2001","journal-title":"N Engl J Med"},{"key":"2020071613171537900_R83","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/10507250360731587","article-title":"Impact of thyroxine-binding globulin on TH economy during pregnancy.","volume":"13","author":"Zigman","year":"2003","journal-title":"Thyroid"},{"key":"2020071613171537900_R84","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1056\/NEJM200106073442302","article-title":"Increased need for thyroxine in women with hypothyroidism during estrogen therapy.","volume":"344","author":"Arafah","year":"2001","journal-title":"N Engl J Med"},{"key":"2020071613171537900_R85","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/mend.14.11.0547","article-title":"Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene.","volume":"14","author":"Kawamoto","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2020071613171537900_R86","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.","volume":"275","author":"Moore","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613171537900_R87","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.61.6_suppl_2.S35","article-title":"Antiepileptic drug pharmacokinetics during pregnancy and lactation","volume":"61","author":"Pennell","year":"2003","journal-title":"Neurology"},{"key":"2020071613171537900_R88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1986.tb02901.x","article-title":"Paracetamol metabolism in pregnancy.","volume":"22","author":"Miners","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"2020071613171537900_R89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.1992.tb04092.x","article-title":"The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women.","volume":"33","author":"Heikkila","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"2020071613171537900_R90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198712020-00004","article-title":"Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.","volume":"12","author":"Philipson","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"2020071613171537900_R91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives.","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"2020071613171537900_R92","first-page":"338","article-title":"Increased metabolic clearance of acetaminophen with oral contraceptive use.","volume":"60","author":"Abernethy","year":"1982","journal-title":"Obstet Gynecol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/995\/9022533\/endo0995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/995\/9022533\/endo0995.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:36:23Z","timestamp":1594942583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/146\/3\/995\/2499895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2004-1350","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}